value shares are a better way to bet on a Covid-19 vaccine than cyclical stocks, even though the latter have gained favor for capturing the trade, according to Goldman Sachs Group Inc.
Value shares beat their growth counterparts by more than 3 percentage points over the Aug. 22 to Sept. 8 period, when the chances of a vaccine available by the first quarter of 2021 jumped to about 70% from around 40%, Goldman strategists led by David Kostin wrote in a note Friday. Cyclical shares underperformed defensive ones, they said.
MMAG-WB 0.365 conversion 1 for 1 at 0.20 expiry 27-11-2022 Now MMAG price at RM 1.92 - conversion at 0.20 = RM 1.72 That mean MMAG WB should be RM 1.72 instead of 0.365 now Don't miss this opportunity is a good buy of price different of RM 1.36 MMAG-WB value in money better by now
However, there is scepticism over whether its ventures will succeed. Leinves PLT chief investment officer William Ng expresses doubts over HWGB’s plan to produce Covid-19 vaccines..... Really no idea who will partner it and on what ground as there are many better options available. ST trading, LT dim.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
nuilam hali
1,365 posts
Posted by nuilam hali > 2020-09-21 20:20 | Report Abuse
value shares are a better way to bet on a Covid-19 vaccine than cyclical stocks, even though the latter have gained favor for capturing the trade, according to Goldman Sachs Group Inc.
Value shares beat their growth counterparts by more than 3 percentage points over the Aug. 22 to Sept. 8 period, when the chances of a vaccine available by the first quarter of 2021 jumped to about 70% from around 40%, Goldman strategists led by David Kostin wrote in a note Friday. Cyclical shares underperformed defensive ones, they said.